Gonasi Set

Gonasi Set contains the active ingredient human chorionic gonadotropin (hCG) and is supplied in an injectable form for intramuscular or subcutaneous administration. It is marketed in the European Union and is available by prescription only. The product mimics luteinizing hormone activity to support ovulation and luteal phase function in fertility treatment and is also used in specific pediatric indications.

Gonasi Set is prescribed for several reproductive and endocrine indications. It is used under medical supervision to assist patients undergoing fertility procedures.

- Induction of ovulation in women with anovulatory infertility. - Luteal phase support in assisted reproductive technology such as IVF. - Treatment of cryptorchidism (undescended testicle) in male infants. - Management of hypogonadotropic hypogonadism when gonadotropin therapy is indicated. - Adjunct therapy in certain cases of male infertility to stimulate testosterone production.

Side effects of Gonasi Set vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common: - Injection site pain, redness, or swelling. - Headache or mild dizziness. - Nausea or abdominal discomfort. - Breast tenderness or swelling. - Transient flu‑like symptoms.

Serious: - Allergic reactions such as rash, itching, or anaphylaxis. - Ovarian hyperstimulation syndrome (OHSS) in women. - Thromboembolic events (rare).

Before using Gonasi Set, clinicians consider several safety factors. Patients should follow medical guidance and report any concerns. - Assess for contraindications such as known hypersensitivity to hCG. - Evaluate risk of ovarian hyperstimulation syndrome in women undergoing fertility treatment. - Monitor for signs of thromboembolic disease, especially in patients with clotting disorders. - Use caution in patients with uncontrolled hypertension or cardiovascular disease. - Discuss potential effects on hormone‑dependent tumors. - Ensure appropriate dosing and timing in pediatric cryptorchidism cases.

Gonasi Set may interact with other medications or substances. Some combinations should be avoided, while others require careful monitoring.

Avoid: - Concurrent use of estrogen‑containing oral contraceptives, which can diminish hCG effectiveness. - High‑dose corticosteroids that may alter hormonal response.

Use with caution: - Anticoagulants, due to potential increased risk of thrombosis. - Thyroid hormone replacement, as hCG can affect thyroid function tests. - Medications that influence the renin‑angiotensin system, requiring blood pressure monitoring. - Other gonadotropins or fertility drugs, to prevent overstimulation.